MK
Indiana University
Ref-1/APE1 inhibitors that disrupt pancreatic cancer metabolism and its response to stress.
In developmentUniversity
Get the Discover digest
Receive a weekly email digest of the latest oncology and cancer therapeutics solutions added by the network.Discover innovations in oncology and cancer therapeutics
Get the Discover digest
Receive a weekly email digest of the latest oncology and cancer therapeutics solutions added by the network.Browse 829 solutions in oncology & cancer therapeutics on the Halo network
Updated Sept 30, 2026
Oncology covers the therapies, delivery systems and models aimed at solid and blood cancers. On Halo, the solutions cover pancreatic cancer, nucleic acid therapy and carriers, immunotherapy inside the tumor, and cell and bacterial therapy. Sign up to search the full network and post your specific need.
Pancreatic cancer
MK
Northwest A&F University
Trienomycin A derivatives hitting PI3K/AKT/mTOR and forcing protective autophagy in pancreatic cells.
In developmentUniversity
SP
Sungkyunkwan University
A microfluidic spheroid system that reproduces the pancreatic tumor microenvironment for screening.
In marketUniversity
Nucleic acid therapy and carriers
DN
Lipo-polymeric nanoparticles carrying mRNA therapy to lung cancer.
In developmentStartup
NG
University of Chicago
A lipid-polymer hybrid nanoparticle that crosses the blood-brain barrier into CNS tumors.
Sponsored researchIn developmentUniversity
Immunotherapy inside the tumor
DG
A CpG formulation retained in the tissue it is injected into, for localized immunostimulation.
In developmentStartup
CG
Riptide Bioscience Inc.
A CD206 agonist that turns tumor-associated macrophages back toward an immune response.
In developmentSupplier
NS
University of California, San Diego
Cowpea mosaic virus injected into the tumor to provoke host immunity.
In developmentUniversity
MD
Navicyte Biotechnologies LLC
Mimics T lymphocyte trafficking so a drug reaches the lymph node and tumor and not the bloodstream.
Co-developmentIn developmentStartup
AS
SignaBlok, Inc.
TREM-1 blockade by a ligand-independent mechanism, with tolerability data behind it.
Co-developmentIn developmentStartup
University of Delaware
Bacterial cyclic-di-AMP used as an immunotherapy adjuvant.
Sponsored researchIn developmentUniversity
Cell and bacterial therapy
JJ
University of Navarra
Engineers BCMA CAR T cells to overexpress a glutamine transporter and hold their function longer.
In developmentUniversity
You're viewing a preview of oncology and cancer therapeutics solutions on Halo.
Sign up free to search the full network and post your specific need.
Already have an account?
Who is working on oncology & cancer therapeutics
Organizations in oncology & cancer therapeutics
Universities, startups, and suppliers with solutions in oncology and cancer therapeutics.
Oncology and cancer therapeutics organizations
.jpg)
Innovators in oncology & cancer therapeutics
Researchers and inventors advancing oncology and cancer therapeutics.
Oncology and cancer therapeutics expertsAbout oncology & cancer therapeutics
Oncology on Halo is weighted toward getting a payload to the tumor: nucleic acid therapies with their own carriers, immunotherapy designed to stay where it is injected, and a notable concentration of pancreatic cancer programs. On Halo it spans six groups, including pancreatic cancer, nucleic acid therapy and carriers, and immunotherapy inside the tumor.
Stage of development. Work on oncology & cancer therapeutics on Halo is split between university programs and companies. 87% are past proof of concept (TRL 4 or higher). Co-development and licensing are the usual partnering routes, and about 26% of the solutions that state terms offer pilot engagements.
Three trends in oncology and cancer therapeutics on Halo
Pancreatic cancer as its own cluster. Three separate programs target pancreatic disease: Ref-1/APE1 inhibition against cancer cell metabolism, Trienomycin A derivatives forcing protective autophagy, and a microfluidic spheroid system built to reproduce that specific microenvironment. One of the hardest indications has pulled its own toolset onto the page.
Carriers designed for one organ. The nucleic acid work is inseparable from its delivery. Lipo-polymeric particles go to lung, DOTAP lipid nanoparticles carry p53 mRNA into breast, and a lipid-polymer hybrid is built to cross the blood-brain barrier. The therapy and the carrier are developed as one object.
Immunotherapy that stays put. Several teams are solving for locality and not potency. A CpG formulation is engineered to be retained in the tissue it enters, a plant virus is given intratumorally, and one delivery platform copies T cell trafficking to reach the lymph node. Systemic immune activation is the thing being designed away from.
788organizations
829solutions listed
50%from university labs
87%past proof of concept
Frequently asked questions
What is oncology and cancer therapeutics?
Oncology covers the drugs, cell therapies and delivery systems aimed at solid and blood cancers. It spans targeted small molecules, nucleic acid therapies with the carriers that get them to a tumor, immunotherapy designed to act locally, and the biomarkers that predict which patient will respond. Pharmaceutical developers and academic cancer centers do the work.
What are examples of oncology and cancer therapeutics?
Five examples of oncology and cancer therapeutics solutions on Halo include:
- Ref-1/APE1 inhibitors that disrupt pancreatic cancer metabolism and its response to stress. (Indiana University)
- Lipo-polymeric nanoparticles carrying mRNA therapy to lung cancer. (RJH Biosciences)
- A CpG formulation retained in the tissue it is injected into, for localized immunostimulation. (Kinimmune, Inc.)
- Engineers BCMA CAR T cells to overexpress a glutamine transporter and hold their function longer. (University of Navarra)
- Biodegradable dendritic particles that keep a drug in the bladder and not washing out. (University of Colorado, Boulder)
Which companies and suppliers are developing oncology and cancer therapeutics?
There are 788 organizations with oncology and cancer therapeutics solutions on Halo, 136 of them universities and research institutions. Among them are Indiana University, Northwest A&F University, and Sungkyunkwan University. Most offer co-development or licensing. Sign up to see every organization working in the area and to send them your specific need.
How do I find oncology and cancer therapeutics research partners?
Browsing oncology and cancer therapeutics solutions on Halo is free. Sign up to search the full network and save the ones you want. Post your specific need to get exact matches. Organizations reply directly on the platform.
Related medicine research areas
Confirm digest type